PDL BioPharma, Inc. Business Combination, Contingent Consideration, Liability
PDL BioPharma, Inc. had Business Combination, Contingent Consideration, Liability of $47.40 million as of 2016-07-01, per its 10-K filed 2019-03-15.
Discontinued › Balance Sheet › Liabilities
us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2019-03-15
- 2016-07-01: Business Combination, Contingent Consideration, Liability $47.40M.
| Period end | Business Combination, Contingent Consideration, Liability |
|---|---|
| 2016-07-01 | $47.40M 10-K · filed 2019-03-15 |